Researchers at the RIKEN Center for Developmental Biology (CDB) have successfully transplanted retinal pigment cells derived from stem cells of one monkey into the eyes of other monkeys without rejection and without the need for immunosuppressant drugs. Published in Stem Cell Reports, the study shows that this procedure is possible as long as a set of cells called the MHC are genetically matched between the host monkey and the new retinal cells.
A realistic hope of modern medicine is to replace damaged tissue with healthy cells grown in the lab. Currently, adult cells can be reprogrammed into stem cells, and then re-differentiated and grown into desired cell types. The researchers at RIKEN CDB led by Masayo Takahashi have already begun a clinical transplant trial in people with age-related macular degeneration. The team grew retinal pigment cells from induced pluripotent stem cells (iPSCs) and transplanted them into the damaged retina of a human participant. In order to avoid tissue rejection, they used autologous iPSCs—iPSCs that were created from the recipient’s own skin cells.
While this method is sound, producing autologous iPSCs is costly. Additionally, because the cells must grow at the same rate as they do during normal development, a person would have to wait more than a year before a transplant could be performed.
Notes lead author Sunao Sugita, “In order to make iPSC transplantation a practical reality, the current goal is to create banks of iPSC-derived tissues that can be transplanted into anyone as they are needed. However, immune responses and tissue rejection are big issues to overcome when transplanting tissue derived from other individuals.”
The new study tested a technique called MHC matching as a way to overcome this issue. Major histocompatibility complexes (MHCs) are a sets of cell-surface proteins found in all cells that function in the immune system. In humans, MHCs are also called human leukocyte antigens (HLAs). There are many genetic variations of MHCs, and after transplantation, if the MHCs of the transplanted cells are not recognized by the T cells of the host immune system, there is an immune response and the tissue is rejected.
To test whether MHC matching is a viable method, the team used retinal pigment cells that were grown from monkey iPSCs in the iPS cell bank at the Center for iPS Cell Research and Application, Kyoto University. They transplanted the cells into the subretinal space in monkeys with either genetically matched or non-matched MHCs.
The researchers found that these transplanted cells survived without rejection for at least 6 months in MHC-matched monkeys, without using any of the usually necessary immunosuppressant drugs. In contrast, rejection was relatively quick in the MHC-mismatched monkeys. Immunohistochemical examination showed that infiltration by inflammatory cells was only present in the transplanted grafts of MHC-mismatched monkeys. In vitro, the team saw that T cells failed to respond to the iPSC-derived retinal pigment cells if they were from an MHC-matched monkey.
In a separate study published in the same issue of Stem Cell Reports, the researchers saw similar results when they repeated this last experiment with human T cells and HLA-matched or unmatched retinal pigment cells grown from IPSCs.
Now that we have established the lack of immune response in monkeys and in human cells in vitro,” explains Sugita, “using the iPS cell bank appears to be a viable solution, at least in the case of retinal pigment epithelial cell transplantation.”
“In the next clinical trial,” continues Sugita, “we plan to use allogeneic iPS-retinal pigment epithelial cells from HLA homozygote donors. The clinical data after the transplantation will allow us to see if the iPS cell bank is truly useful or not. If so, I think this type of transplantation can become standard treatment within 5 years.”
Learn more: Success! iPSC-derived retinal cells from one monkey transplanted into another without rejection
The Latest on: iPSC transplantation
[google_news title=”” keyword=”iPSC transplantation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: iPSC transplantation
- Intestine Transplantationon April 25, 2024 at 5:00 pm
The international experience of small bowel transplantation since 1985 has been compiled and analyzed through the International Intestinal Transplant Registry. [10] As of May 2001, the Registry ...
- Heart Transplantation for a Prisoneron April 23, 2024 at 5:00 pm
Stanford University Medical Center has received some recent press coverage centered around a controversial decision to provide a heart transplant to a convicted felon serving time in the ...
- Medicare ignored expert advice to cut tests for transplant patients: Reporton April 19, 2024 at 3:55 pm
Contractors for the Centers for Medicare and Medicaid Services (CMS) cut access to tests for transplant patients that could show early signs of organ rejection despite expert physicians advising ...
- The Bone-Marrow-Transplant Revolutionon April 17, 2024 at 5:00 pm
In cases like his, the ideal treatment is a transplant. Arias’s cancer-prone blood cells needed to be destroyed and replaced with healthy ones taken from the bone marrow or blood of a donor who ...
- Organ-transplant container falls out the back of rushing NYC medical supply truckon April 13, 2024 at 8:38 am
citizen That’s what happens when ur-ine a rush! An apparent organ-transplant container fell out of the back of a medical supply truck in Sunnyside, Queens, according to a shocked user on the ...
- Transplant doctor accused of secretly denying new livers to patients who later diedon April 12, 2024 at 12:36 pm
A Texas transplant doctor has been accused of manipulating records for liver transplant candidates, causing a Houston medical centre’s liver and kidney transplant programmes to be halted.
- He Got a Pig Kidney Transplant. Now Doctors Need to Keep It Workingon April 5, 2024 at 10:26 am
I just saw him this morning. He’s all smiles,” said Leonardo V. Riella, medical director for kidney transplantation at Mass General, in an interview Friday. Slayman’s procedure represents a ...
- 'New beginning': First man to successfully receive pig kidney transplant gets discharged from hospitalon April 5, 2024 at 10:08 am
Following his discharge from the hospital, the first man to receive a successful kidney transplant from a pig said the moment was "one of the happiest" of his life and marked a "new beginning" for ...
- First Pig Kidney Transplant Patient Goes Homeon April 4, 2024 at 7:19 am
In 1995, Cambridge University transplant surgeon Roy Calne suggested that xenotransplantation "is just around the corner, but it may be a very long corner." The preliminary success of Slayman's ...
via Bing News